The influence of IL-6 receptor blockade on appetite regulation after high-intensity exercise in healthy males
Contrary to the hypothesis that IL-6 receptor blockade would increase food intake by attenuating exercise-induced anorexia, this study found that blocking the receptor actually reduced post-exercise hunger and prospective food consumption in healthy males, likely due to increased perceived exertion.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For decades, scientists have known that a hard workout changes how we feel, not just in our muscles but in our minds. One of the most consistent effects is a temporary loss of appetite. After a grueling session of exercise, many people find they simply do not want to eat, a phenomenon researchers call exercise-induced anorexia. This is more than just a fleeting feeling; it is a biological response where the body seems to hit a pause button on hunger, even when energy has been burned. To understand why this happens, researchers have looked at the chemicals our bodies release during physical strain. One such chemical is interleukin-6, a signaling molecule produced by muscles when they work hard. In the lab, high levels of this molecule have been shown to suppress the desire to eat in animals, leading to a logical question for human health: does this same chemical act as the switch that turns off hunger in people after they exercise? If it does, then blocking its action might stop that appetite suppression, potentially helping people eat more after a workout if they need to recover.
A team of researchers at Copenhagen University Hospital set out to test this idea in healthy men. They designed a study to see what would happen if they stopped the body from receiving the signals of interleukin-6. The scientists recruited twenty-nine men who were active but not elite athletes. On a specific test day, each man received an infusion of either a saline solution or a drug that blocks the receptor for interleukin-6, effectively silencing the chemical's message. After the infusion, all the men completed a demanding high-intensity cycling session. The workout was designed to be exhausting, pushing their heart rates to near maximum levels for several intervals. Three hours after the ride, the men were served a large, free-flowing meal of spaghetti bolognese and told to eat as much as they wanted. Throughout the day, the researchers tracked how hungry the men felt, how much they actually ate, and what was happening in their blood.
The results surprised the scientists. They had expected that blocking the hunger-suppressing chemical would make the men feel hungrier and eat more. Instead, the opposite occurred. The men who received the drug to block interleukin-6 reported feeling significantly less hungry than the men who received the saline. They also felt less like they could eat a large meal and reported a lower overall desire to consume food. When it came time to eat, the men in the blocked group ate slightly less food than the control group, though the difference in the amount of pasta and sauce consumed was not large enough to be considered statistically certain. The most striking finding was that the men who could not receive the interleukin-6 signal felt a stronger sense of fullness and satisfaction after eating, and their feelings of hunger remained lower for longer after the meal compared to the other group.
The researchers looked closely at other factors to explain this unexpected drop in appetite. They considered whether the drug made the men feel sick or nauseous, but the reports of nausea were similar in both groups. They also checked if the drug changed how quickly food left the stomach or if it altered the levels of other hormones known to control hunger, such as glucagon-like peptide-1. None of these factors showed a difference between the two groups. The only clear difference the researchers found was in how the men perceived the effort of the exercise itself. The men who received the blocking drug rated their workout as feeling more strenuous and less pleasant than the men in the control group. This suggests that the drug may have made the physical strain feel heavier, and that this increased sense of effort, rather than the chemical itself, was what lowered their appetite.
This study suggests that the idea of interleukin-6 acting as a direct hunger switch in humans might be incorrect, at least under these conditions. The researchers found that stopping the chemical did not restore appetite; it seemed to dampen it further. The findings point toward a more complex picture where the feeling of how hard the body is working plays a major role in deciding whether to eat. While the study did not prove that interleukin-6 has no role in appetite, it strongly indicates that blocking it does not help people eat more after exercise. Instead, the data implies that the subjective experience of the workout, the feeling of strain and effort, might be the more powerful driver of post-exercise hunger than the specific chemical signals previously suspected.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.